hydralazine has been researched along with guaiacol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Baltas, M; Bedos-Belval, F; Belkheiri, N; Bouguerne, B; Duran, H; Grazide, MH; Nègre-Salvayre, A; Salvayre, R; Uchida, K; Vindis, C | 1 |
2 other study(ies) available for hydralazine and guaiacol
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Antiatherogenic effect of bisvanillyl-hydralazone, a new hydralazine derivative with antioxidant, carbonyl scavenger, and antiapoptotic properties.
Topics: Animals; Antioxidants; Apoptosis; Atherosclerosis; Cell Adhesion; Cells, Cultured; Chelating Agents; Chemokine CCL2; Endothelial Cells; Enzyme Activation; Foam Cells; Guaiacol; Humans; Hydralazine; Lipid Peroxidation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Oxidative Stress; Plaque, Atherosclerotic; Proteasome Endopeptidase Complex; Protein Carbonylation; Reactive Oxygen Species | 2011 |